Idea principal
In 86 healthcare workers given two doses of the Pfizer/BioNTech vaccine, larger waist circumference (R = -0.324, p = 0.004), smoking, hypertension and longer time since the second dose were associated with lower antibody titres. The sample was small and antibody level is only a surrogate for protection.
Study design
Artículo de investigación
Reading basis
Published abstract
Reading focus
Design & applicability
Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.
Pregunta de investigación
Antibody response to COVID-19 vaccines varies between people. The authors looked for health and lifestyle factors associated with how strong the antibody response was after mRNA vaccination.
Población y método
Observational study of 86 healthcare workers enrolled in January-February 2021, each given two Pfizer/BioNTech mRNA vaccine doses 3 weeks apart. Blood was drawn before the first dose and 1-4 weeks after the second. Clinical history, demographics and vaccine side effects were recorded, anthropometrics were measured, and body composition was assessed by dual-energy X-ray absorptiometry. Multivariate analysis adjusted for BMI, age and gender.
Resultados
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1A larger waist circumference was associated with lower antibody titres (R = -0.324, p = 0.004).
- 2Smokers had lower titres than non-smokers (1099 [1350] vs 1921 [1375], p = 0.007), as did people with hypertension versus normal blood pressure (650 ± 1192 vs 1911 [1364], p = 0.001) and with dyslipidaemia versus normal lipids (534 [972] vs 1872 [1406], p = 0.005).
- 3In multivariate analysis, higher waist circumference, smoking, hypertension and longer time since the second dose were each associated with lower titres, independent of BMI, age and gender.
Límites e incertidumbre
- 1Only 86 healthcare workers took part, and the groups (for example smokers or hypertensive people) were likely small.
- 2Antibody titres were the only outcome; the authors state it is not possible to say whether lower antibodies mean a higher likelihood of COVID-19.
- 3Samples were taken 1-4 weeks after the second dose, so timing differed between people and longer-term responses are not captured.
- 4Association only: the abstract does not show that these factors cause the lower response. This reading is based on the abstract only.
Relevancia práctica
Waist size, smoking and blood pressure were linked to a weaker antibody response in this small group, which is one more reason these health factors matter. It does not show anyone is unprotected; decisions about boosters or schedules follow public health guidance and clinicians.
Tus datos
Waist circumference measured the same way at the same time of day, and home blood pressure readings from a validated cuff, are the closest personal measures. Antibody levels themselves are lab tests and cannot be tracked at home.
Cómo interpretar la evidencia
The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.
Resumen estructurado de los autores English
El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.
Aims
To explore variables associated with the serological response following COVID-19 mRNA vaccine.
Methods
Eighty-six healthcare workers adhering to the vaccination campaign against COVID-19 were enrolled in January-February 2021. All subjects underwent two COVID-19 mRNA vaccine inoculations (Pfizer/BioNTech) separated by 3 weeks. Blood samples were collected before the 1st and 1-4 weeks after the second inoculation. Clinical history, demographics, and vaccine side effects were recorded. Baseline anthropometric parameters were measured, and body composition was performed through dual-energy-X-ray absorptiometry.
Results
Higher waist circumference was associated with lower antibody (Ab) titres (R = -0.324, p = 0.004); smokers had lower levels compared to non-smokers [1099 (1350) vs. 1921 (1375), p = 0.007], as well as hypertensive versus normotensive [650 ± 1192 vs. 1911 (1364), p = 0.001] and dyslipideamic compared to those with normal serum lipids [534 (972) vs 1872 (1406), p = 0.005]. Multivariate analysis showed that higher waist circumference, smoking, hypertension, and longer time elapsed since second vaccine inoculation were associated with lower Ab titres, independent of BMI, age. and gender.
Conclusions
Central obesity, hypertension, and smoking are associated with lower Ab titres following COVID-19 vaccination. Although it is currently impossible to determine whether lower SARS-CoV-2 Abs lead to higher likelihood of developing COVID-19, it is well-established that neutralizing antibodies correlate with protection against several viruses including SARS-CoV-2. Our findings, therefore, call for a vigilant approach, as subjects with central obesity, hypertension, and smoking could benefit from earlier vaccine boosters or different vaccine schedules.
Fuentes y atribución
Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID-19 mRNA vaccine.
Watanabe M, Balena A, Tuccinardi D, Tozzi R, Risi R, Masi D, Caputi A, Rossetti R, Spoltore ME, Filippi V, Gangitano E, Manfrini S, Mariani S, Lubrano C, Lenzi A, Mastroianni C, Gnessi L.
Diabetes/metabolism research and reviews · 2021-05-11
DOI: 10.1002/dmrr.3465 ↗PubMed · 33955644 ↗Europe PMC · Licencia registrada: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada
Fuentes verificadas 2026-11-01
Guías prácticas
Leer en contexto
Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people
Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.
Journal of the American Heart Association
Five exercise types lowered resting blood pressure, isometric training the most
Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.
British Journal of Sports Medicine
A salt substitute lowered stroke, major cardiovascular events and death in rural China
In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.
The New England Journal of Medicine
Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation
Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.
The New England Journal of Medicine

